GlaxoSmithKline Pharmaceuticals AR 2013 - page 6

2
Performance Summary
(Amounts in Rupees Lakhs)
2013*
2012*
2011*
2010
2009
2008
2007
2006
2005
2004
PROFIT AND LOSS ACCOUNT
Sales
2593,39
2669,97
2391,73
2155,08
1912,77
1751,56
1712,84
1677,57
1575,89
1479,59
Profit before tax
703,17
994,78
921,60
867,27
758,48
679,90
606,73
555,95
477,91
418,24
Tax
(226,19)
(317,59)
(290,24)
(285,89)
(253,59)
(231,54)
(209,94)
(194,23)
(171,63)
(152,19)
Profit after tax and before exceptional items
476,98
677,19
631,36
581,38
504,89
448,36
396,79
361,72
306,28
266,05
Exceptional items (net of tax)
24,90
(99,93)
(200,76)
(17,69)
7,40
128,21
140,87
183,79
195,80
67,04
Net Profit
501,88
577,26
430,60
563,69
512,29
576,57
537,66
545,51
502,08
333,09
Balance brought forward
1142,95
1110,59
1164,53
1049,23
882,41
759,89
632,75
441,19
259,75
196,93
Dividends
(423,51)
(423,51)
(381,16)
(338,81)
(254,11)
(338,81)
(304,93)
(262,58)
(237,17)
(209,57)
Tax on distributed profit
(71,19)
(63,66)
(60,32)
(53,21)
(40,13)
(57,58)
(51,82)
(36,82)
(33,26)
(27,39)
Transfer to General Reserve
(50,19)
(57,73)
(43,06)
(56,37)
(51,23)
(57,66)
(53,77)
(54,55)
(50,21)
(33,31)
Balance carried forward
1099,94
1142,95
1110,59
1164,53
1049,23
882,41
759,89
632,75
441,19
259,75
BALANCE SHEET
Equity Capital
84,70
84,70
84,70
84,70
84,70
84,70
84,70
84,70
84,70
87,32
Reserves
1932,49
1925,31
1835,23
1846,11
1674,45
1456,39
1276,21
1110,01
863,91
836,94
Borrowings
4,14
4,59
4,91
5,16
5,42
5,65
5,77
5,54
4,85
3,85
2021,33
2014,60
1924,84
1935,97
1764,57
1546,74
1366,68
1200,25
953,46
928,11
Fixed Assets
161,93
133,19
115,32
117,65
114,17
100,35
92,90
94,46
96,94
91,49
Investments
57,67
102,58
159,80
160,35
190,91
751,87
1333,32
1139,41
913,06
776,82
Net Deferred Tax
92,11
86,54
61,47
56,40
44,69
29,60
20,14
24,61
29,76
44,86
Net Assets (Current and Non-Current)
1709,62
1692,29
1588,25
1601,57
1414,80
664,92
(79,68)
(58,23)
(86,30)
14,94
2021,33
2014,60
1924,84
1935,97
1764,57
1546,74
1366,68
1200,25
953,46
928,11
* 2013, 2012 and 2011 based on Revised Schedule VI
OTHER KEY DATA
Rupees per Rs.10/- Equity Share
DIVIDENDS
50.00
50.00
45.00
40.00
30.00
22.00
18.00
17.00
14.00
13.00
SPECIAL ADDITIONAL DIVIDEND
— — 18.00
18.00
14.00
14.00
11.00
TOTAL
50.00
50.00
45.00
40.00
30.00
40.00
36.00
31.00
28.00
24.00
Earnings per equity share
59.25
68.15
50.84
66.55
60.48
68.07
63.48
64.40
58.51
38.15
BOOK VALUE
238.16
237.31
226.67
227.96
207.69
181.95
160.67
141.05
112.00
105.85
Number of employees
5034
4706
5055
4338
4006
3722
3620
3850
4016
4136
NOTES
1.
The Company has divested its Fine Chemicals business on 30th September, 2007 and its Animal Health business on 31st July, 2006.
2.
The Company has bought back and extinguished 26,19,529 equity shares during 2005.
3.
Burroughs Wellcome (India) Limited merged with the Company from 1.1.2004.
4.
Profit And Loss Account balance brought forward as on 1.1.2004 includes Rs. 533 lakhs transferred from erstwhile Burroughs Wellcome (India) Limited, pursuant to the Scheme of
Amalgamation.
5.
Figures have been adjusted/regrouped wherever necessary in line with the financial statements, to facilitate comparison.
Charts
1,2,3,4,5 7,8,9,10,11,12,13,14,15,16,...100
Powered by FlippingBook